Stanford researchers will discuss their agentic 'scientists' that are on course to reshape drug discovery at VB Transform 2026 (opens original article in a new tab)

Stanford researchers will discuss agentic 'scientists' at VB Transform 2026, which could improve drug discovery efficiency by addressing workflow inefficiencies and high failure rates.

• Stanford researchers will present agentic 'scientists' at VB Transform 2026
• Agentic scientists aim to improve drug discovery efficiency
• Drug discovery has high failure rates due to inefficient workflows